Montis’ mission is to therapeutically exploit cellular interactions between perivascular macrophages and tumor vasculature to drive and sustain immune reactions against solid tumors.
Location: Belgium, Flemish Brabant, Leuven
Investors 2
| Date | Name | Website |
| - | Droia Onco... | droiaventu... |
| - | KU Leuven ... | lrd.kuleuv... |
Mentions in press and media 2
| Date | Title | Description |
| 14.06.2021 | Montis Biosciences Awarded VLAIO Grant to Expand its Pipeline of Novel Immune-Oncology Therapeutics | Leuven, Belgium, 14 June 2021 -Montis Biosciences, a Belgium-based biotech company focused on the development of novel immuno-oncology therapeutics tar
|